Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DICLOFENAC Cause Ankylosing spondylitis? 874 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 874 reports of Ankylosing spondylitis have been filed in association with DICLOFENAC (Diclofenac Sodium Delayed Release). This represents 1.0% of all adverse event reports for DICLOFENAC.

874
Reports of Ankylosing spondylitis with DICLOFENAC
1.0%
of all DICLOFENAC reports
1
Deaths
64
Hospitalizations

How Dangerous Is Ankylosing spondylitis From DICLOFENAC?

Of the 874 reports, 1 (0.1%) resulted in death, 64 (7.3%) required hospitalization, and 20 (2.3%) were considered life-threatening.

Is Ankylosing spondylitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DICLOFENAC. However, 874 reports have been filed with the FAERS database.

What Other Side Effects Does DICLOFENAC Cause?

Drug ineffective (24,885) Product use in unapproved indication (12,197) Off label use (10,370) Pain (9,276) Product use issue (8,009) Fatigue (7,908) Rash (7,852) Rheumatoid arthritis (7,366) Abdominal discomfort (7,257) Product administered at inappropriate site (6,919)

What Other Drugs Cause Ankylosing spondylitis?

CERTOLIZUMAB PEGOL (2,580) ADALIMUMAB (2,378) SECUKINUMAB (1,942) ETANERCEPT (1,456) METHOTREXATE (1,067) INFLIXIMAB (789) GOLIMUMAB (643) LEFLUNOMIDE (413) CELECOXIB (329) SULFASALAZINE (250)

Which DICLOFENAC Alternatives Have Lower Ankylosing spondylitis Risk?

DICLOFENAC vs DICLOFENAC DIETHYLAMINE DICLOFENAC vs DICLOFENAC EPOLAMINE DICLOFENAC vs DICLOFENAC\DICLOFENAC DICLOFENAC vs DICLOFENAC\MISOPROSTOL DICLOFENAC vs DICLOXACILLIN

Related Pages

DICLOFENAC Full Profile All Ankylosing spondylitis Reports All Drugs Causing Ankylosing spondylitis DICLOFENAC Demographics